P2 purine and pyrimidine receptors: Emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors

European Journal of Medicinal Chemistry

Volumn 32, Issue 3, 1997, Pages 183-193

  Bhagwat, S S ^a   Williams, M ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

P2 receptor; Purine receptor; Pyrimidine receptor

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ADENOSINE TRIPHOSPHATE DERIVATIVE; ANTITRYPANOSOMAL AGENT; EVANS BLUE; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; METHYLXANTHINE DERIVATIVE; PURINE P2 RECEPTOR; RECEPTOR; SULFONIC ACID DERIVATIVE; SURAMIN;

ANIMAL TISSUE; CATTLE; CHICKEN; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; RAT; REVIEW; TURKEY (BIRD);

EID: 0030958195     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)83970-0     Document Type: Review

References (141)

1. 1 Burnstock G (1996) Ciba Foundation Symp 198, 1-34
2. 2 Zimmerman H (1994) Trends Neurosci 17, 420-426
3. 3 Harden TK, Boyer JL, Nicholas RA (1995) Ann Rev Pharmacol Toxicol 35, 541-579
4. 4 Weisman GA, Turner JT, Fedan JS (1996) J Pharmacol Exp Ther 277, 1-9
5. 5 Boarder MR, Weisman GA, Turner JT, Wilkinson GF (1995) Trends Pharmacol Sci 16, 133-139
6. 6 Williams M, Bhagwat SS (1996) Ann Rep Med Chem 31, 21-30
7. 7 Inoue K, Koizumi S, Ueno S (1996) Prog Neurobiol 50, 483-492
8. 8 Buell G, Collo G, Rassendren F (1996) Eur J Neurosci 8, 2221-2228
9. 9 Burnstock G, Barnard EA (1996) Ciba Foundation Symp 198, 261-265
10. 10 Humphrey PPA, Buell G, Kennedy I et al (1995) Naunyn-Schmideberg's Arch Pharmacol 352, 585-596
11. 11 North RA (1996) Seminar Neurosci 8, 187-194
12. 12 Burnstock G, King BE (1996) Drug Dev Res 38, 67-71
13. 13 Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trends Neurosci 19, 13-17
14. 14 Freund H (1920) Arch Exp Pathol Pharmacol 86, 267-268
15. 15 Drury AN, Szent-Gyorgi A (1929) J Physiol (Lond) 68, 213-237
16. 16 Holton P (1959) J Physiol (Lond) 145, 494-504
17. 17 Burnstock G, Campbell G, Satchell D, Smythe A (1970) Br J Pharmacol 40, 668-688
18. 18 Burnstock G (1972) Pharmacol Rev 24, 509-581
19. 19 Burnstock G (1978) In: Cell Membrane Receptors for Drugs and Hormones (Bolis L, Straub RW, eds) Raven, New York, 107-118
20. 20 Fredholm BB, Abbracchio, NP, Burnstock G et al (1994) Pharmacol Rev 46, 143-156
21. 21 Burnstock, G (1996) Drug Dev Res 39 (in press)
22. 22 Miyashita Y, Kumazawa T, Fujii R (1984) Comp Biochem Physiol 77C, 205-210
23. 23 Williams M, Burnstock G. (1997) In: Purinergic Approaches in Experimental Therapeutics (Jacobson KA, Jarvis MF, eds) Wiley, Liss, New York (in press)
24. 24 Williams M (1995) In: Psychopharmacology, The Fourth Generation of Progress (Bloom FE, Kupfer DJ, eds) Raven, New York, 643-655
25. 25 Hourani SMO, Hall DA (1994) Trends Pharmacol Sci 15, 103-108
26. 26 Williams M, Braunwalder A (1986) J Neurochem 47, 88-93
27. 27 Zhang Y, Palmblad, Fredholm BB (1996) Biochem Pharmacol 51, 957-965
28. 28 Atkinson DE (1977) Cellular Energy Metabolism and Its Regulation, Academic, San Diego, CA
29. 29 Evans RJ, Derkach V, Surprenant A (1992) Nature 357, 503-505
30. 30 Edwards FA, Gibb AJ, Colquhoun D (1992) Nature 359, 144-147
31. 31 Prince DA, Stevens CF (1992) Proc Natl Acad Sci USA 89, 8586-8590
32. 32 Kennedy C, Leff P (1995) Trends Pharmacol Sci 16, 168-174
33. 33 Cronstein BN, Bouma MG, Becker BF (1996) Drug Dev Res 39 (in press)
34. 34 Dubyak GR, Clifford, EE, Humphreys BD, Kertesy SB, Martin KA (1996) Drug Dev Res 39 (in press)
35. 35 Burnstock G, Kennedy C (1985) Gen Pharmacol 16, 433-440
36. 36 Gordon J (1986) Biochem J 233, 309-319
37. 37 Abbracchio MP, Cattabeni F, Fredholm BB, Williams M (1993) Drug Dev Res 28, 207-213
38. 38 Fredholm BB, Abbracchio MP, Burnstock G et al (1997) Trends Pharmacol Sci (in press)
39. 39 Dubyak GR, El-Moatassim G (1993) Am J Physiol 265, 577C-606C
40. 40 Abbracchio MP, Burnstock G (1994) Pharmacol Ther 64, 445-475
41. 41 Vanhoutte PM, Humphrey PPA, Spedding M (1996) Pharmacol Rev 48, 1-2
42. 42 Lustig KD, Shiau AK, Brake AJ, Julius D (1993) Proc Natl Acad Sci USA 90, 5113-5117
43. 43 Parr CE, Sullivan DM, Paradiso AM et al (1994) Proc Natl Acad Sci USA 91, 3275-3279
44. 44 Lazarowski ER, Hardin TK (1994) J Biol Chem 269, 11830-11836
45. 45 Nicholas RA, Watt WC, Lazorowski ER, Li Q, Harden TK (1996) Mol Pharmacol 50, 224-229
46. 46 Nguyen T, Erb L, Weisman GA et al (1995) J Biol Chem 270, 30845-30848
47. 47 Communi D, Pirotton S, Parmentier M, Boeynaems JM (1995) J Biol Chem 270, 30849-30855
48. 48 Boeynaems JM, Communi, D, Pirotton S, Motte, Parmentier M (1996) Ciba Found Symp 198, 266-277
49. 49 Valera S, Hussy N, Evans RJ et al (1994) Nature 371, 516-519
50. 50 Brake AJ, Wagenbach MJ, Julius D (1994) Nature 371, 519-523
51. 51 Nuttle LC, Dubyak GR (1994) J Biol Chem 269, 13988-13996
52. 52 Di Virgilio F (1995) Immunol Today 16, 524-528
53. 53 Suprenant A, Rassendren FA, Kawashima E, North RA, Buell G (1996) Science 272, 735-738
54. 54 Pintor J, Miras-Portugal MT (1995) Gen Pharmacol 26, 229-235
55. 55 Varsgavasky A (1984) Cell 34, 711-712
56. 56 Walker J, Lewis TE, Pivorun EP, Hilderman RH (1993) Biochem 32, 1264-1269
57. 57 Lazarowksi ER, Watt WC, Stuts MJ, Boucher RC, Harden TK (1995) Br J Pharmacol 116, 1619-1627
58. 58 Zamecnik PC, Byung K, Gao MJ, Taylor G, Blackburn M (1992) Proc Natl Acad Sci USA 89, 2370-2373
59. 59 Van Rhee, M, Jacobson KA (1996) Drug Dev Res 37, 1-38
60. 60 Chalfie M, Au M (1989) Science 243, 1027-1033
61. 61 Canessa CM, Horisberger JD, Rossier BC (1993) Nature 361, 467-470
62. 62 Nicke A, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G (1996) Drug Dev Res 37, 115
63. 63 McKernan RM, Whiting PJ (1996) Trends Neurosci 19, 139-143
64. 64 Seeburg PH (1996) J Neurochem 66, 1-5
65. 65 Arneric SP, Sullivan JP, Williams M (1995) In: Psychopharmacology, The Fourth Generation of Progress (Bloom FE, Kupfer DJ, eds) Raven, New York, 94-110
66. 66 Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN (1995) Nature 377, 428-431
67. 67 Burnstock G, Wood JN (1996) Curr Opinion Neurobiol 6, 526-532
68. 68 Burnstock G (1996) Lancet 347, 1604-1605
69. 69 Thorne PR, Housley GD (1996) Seminar Neurosci 8, 233-246
70. 70 Williams M, Jacobson KA (1995) Exp Opin Invest Drugs 4, 925-934
71. 71 Cusack NJ (1993) Drug Dev Res 28, 244-252
72. 72 Fischer B, Boyer JL, Hoyle CHV et al (1993) J Med Chem 36, 3937-3946
73. 73 Jacobson KA, Fischer B, Malliard M et al (1995) In: Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology (Bellardinelli L, Pelleg A, eds) Kluwer, Boston, 149-156
74. 74 Fischer B, Yefidof R, Boyer JL, Harden TK, Jacobson KA (1996) Drug Dev Res 37, 132
75. 75 Jacobson KA, Suzuki F (1996) Drug Dev Res 39 (in press)
76. 76 Jacobson KA, Van Galen PJM, Williams M (1992) J Med Chem 35, 407-422
77. 77 Crack BE, Pollard CE, Beukers SM et al (1995) Br J Pharmacol 114, 475-481
78. 78 Boyer JL, Siddiqi S, Fischer B, Romero-Avila T, Jacobson KA, Harden TK (1996) Br J Pharmacol 118, 1959-1964
79. 79 Uri A, Jarlebark L, von Kugelgen I, Schonberg T, Unden A, Heilbronn E (1994) Bioorg Med Chem 2, 1099-1105
80. 80 Bultmann R, Pause B, Wittenburg H, Kurz G, Starke K (1996) Naunyn-Schmiedebergs Arch Pharmacol 354, 481-490
81. 81 Voogd TE, Vansterkenberg EL, Wilting J, Janssen LH (1993) Pharmacol Rev 45, 177-203
82. 82 Freissmuth M, Boehm S, Beindl W, Nickel P, Ijzerman AP, Hohenegger M, Nanoff C (1996) Mol Pharmacol 49, 602-611
83. 83 van Rhee AM, van der Heijden MPA, Beukers MW, Ijzerman AP, Soudijn W Nickel P (1994) Eur J Pharmacol 268, 1-7
84. 84 Vigne P, Pacaud P, Urbach V, Feolde F, Breittmayer JP, Frelin C (1996) Br J Pharmacol 119, 360-364
85. 85 Bultmann R, Wittenburg H, Pause B, Kurz G, Nickel P, Starke K (1996) Naunyn-Schmiedebergs Arch Pharmacol 354, 498-504
86. 86 Mateo J, Rotllan P, Miras-Portugal MT (1996) Br J Pharmacol 119, 1-2
87. 87 Nakazawa K, Inoue K, Ito K, Keizumi K (1995) Naunyn-Schmiedebergs Arch Pharmacol 351, 202-208
88. 88 Wittenburg H, Bultmann R, Pause B, Ganter C, Kurz G, Starke K (1996) Naunyn-Schmiedebergs Arch Pharmacol 354, 491-497
89. 89 Boyer JL, Romero-Avila, Schachter JB, Harden (1996) Mol Pharmacol 50, 1323-1329
90. 90 Humphries RG, Tomlinson W, Ingall AH, Cage PA, Leff P (1994) Br J Pharmacol 113, 1057-1063
91. 91 Humphries RG, Robertson MJ, Leff P (1995) Trends Pharmacol Sci 16, 179-181
92. 92 Pendergast W, Sidiqi SM, Rideout JL, James MK, Dougherty RW (1996) Drug Dev Res 37, 133
93. 93 Speeding M, Sweetman AJ, Weetman DF (1975) Br J Pharmacol 53, 575-583
94. 94 King BF, Dacquet C, Ziganshin AU et al (1996) Br J Pharmacol 117, 1111-1118
95. 95 Michel AD, Miller KJ, Buell G, Lundstrom K, Humphrey PPA (1996) Drug Dev Res 37, 113
96. 96 Harden TK (1996) Ciba Foundation Symp 198, 183-185
97. 97 Michel AD, Lundstrom K, Buell GN, Surprenant A, Valera S, Humphrey PPA (1996) Br J Pharmacol 118, 1806-1812
98. 98 Simon J, Webb TE, King BF, Burnstock G, Barnard EA (1995) Eur J Pharmacol 291, 281-289
99. 99 Michel AD, Grahames CBA, Humphrey PPA (1996) Naunyn-Schmiedebergs Arch Pharmacol 354, 562-571
100. 100 Williams M (1996) Ciba Foundation Symp 198, 183-185
101. 101 Clunes MT, Kemp PJ (1996) Cell Calcium 20, 339-346
102. 102 Stroboek D, Christophersen P, Dissing S, Oleson SP (1996) Am J Physiol Cell Physiol 271, C1463-C1471
103. 103 Firestein BL, Xing MZ, Hughes RJ, Corvera CU, Insel PA (1996) Am J Physiol Renal Fluid Electrolyte Physiol 271, F610-F618
104. 104 Seifert R, Schultz G (1989) Trends Pharmacol Sci 10, 365-369
105. 105 Nissui Pharm KK (1993) Japanese Patent, 05059087-A
106. 106 Myers CS, Napolitano M, Fisher H, Wagner GC (1993) Proc Soc Exp Biol Med 204, 49-53
107. 107 Myers CS, Fisher H, Wagner GC (1994) Brain Res 651, 194-198
108. 108 Boucher RC, Knowles MR, Olivier KN, Bennett W, Mason SJ, Stutts MJ (1995) In: Adenosine and Adenine Nucleotides Nucleotides: From Molecular Biology to Integrative Physiology (Bellardinelli L, Pelleg A, eds) Kluwer, Boston, 525-532
109. 109 Bennett WD, Olivier KN, Zeman KL, Hohneker KW, Boucher RC, Knowles MR (1996) Am J Respir Crit Care Med 153, 1796-1801
110. 110 Rapaport E (1993) Drug Dev Res 28, 428-431
111. 111 Bodin P, Burnstock G (1996) J Cardiovasc Pharmacol 27, 872-875
112. 112 Lawson M (1996) BioWorld, December 4, 8
113. 113 Daneryd P, Westlin T, Edstrom S, Soyssi B (1995) Eur J Cancer 31A, 2309-2315
114. 114 Anon (1995) Bioworld, December 28, 6 (247)
115. 115 Coutinho-Silva R, Alves LA, De Carvalho ACC, Avino W, Persechini PM (1996) Biochim Biophys Acta Bio-Membr 1280, 217-222
116. 116 Fyffe REW, Perl ER (1984) Proc Natl Acad Sci USA 81, 6890-6893
117. 117 Nakamura F, Strittmatter SM (1996) Proc Natl Acad Sci USA 93, 10465-10470
118. 118 Sylven C (1993) Cardiovasc Drugs Ther 7, 745-759
119. 119 Sawynok J, Sweeney MI (1989) Neuroscience 32, 557-569
120. 120 Sollevi A, Belfrage M, Lundeberg T, Segerdahl M, Hansson P (1995) Pain 61, 155-158
121. 121 Karlsten R, Gordh Jr T (1995) Anesth Analg 80, 844-847
122. 122 Burnstock G (1989) Biomed Pharmacother 43, 727-736
123. 123 Fukunaga AF, Miyamoto TA, Kikuta Y, Kaneko Y, Ichinohe T (1995) In: Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology (Bellardinelli L, Pelleg A, eds) Kluwer, Boston, 511-525
124. 124 Segerdahl M, Persson E, Ekblom A, Sollevi A (1996) Acta Anaesthesiol Scand 40, 792-797
125. 125 Hillaire-Buys D, Bertrand G, Chapal J, Peuch R, Ribes G, Loubatieres-Mariani MM (1993) Br J Pharmacol 109, 183-187
126. 126 Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement IV JP, Gonzalez G, Aguilar-Bryan L, Permutt MA, Bryan J (1996) Science 272, 1785-1787
127. 127 Ripoll C, Martin F, Rovira JM, Pintor J, Miras-Portugal MT, Soria B (1996) Diabetes 45, 1431-1434
128. 128 Proctor RA, Denlinger L, Leventhal PS et al (1994) Proc Natl Acad Sci USA 91, 6017-6020
129. 129 Denlinger LC, Fisette PL, Garis KA et al (1996) J Biol Chem 271, 337-341
130. 130 Verghese MW, Kneisler TB, Boucheron JA (1996) J Biol Chem 271, 15597-15601
131. 131 Ventura MA, Thomopoulos P (1995) Mol Pharmacol 47, 104-114
132. 132 Jamieson GP, Snook MB, Thurlow PJ, Wiley JS (1996) J Cell Physiol 166, 637-642
133. 133 Yu H, Ferrier J (1993) Biochem Biophys Res Comm 191, 357-363
134. 134 Kaplan AD, Kilkenny DM, Hill DJ, Dixon ST (1996) Endrocrinol 137, 4757-4766
135. 135 Shimegi S (1996) Calcif Tissue Inter 58, 109-113
136. 136 Foresta C, Rosato M, Chiozzi P, Di Virgilio F (1996) Am J Physiol Cell Physiol 270, C1709-C1714
137. 137 Churchill PC, Ellis VR (1993) J Pharmacol Exp Ther 266, 160-163
138. 138 Wang Y, Roman R, Lidoski SD, Fitz JS (1996) Proc Natl Acad Sci USA 93, 12020-12025
139. 139. Silver R, Silverman AJ, Vitkovic L, Lederhendler II (1996) Trends Neurosci 19, 25-31
140. 140 Freedman JE, Lin YJ (1996) Neuroscientist 2, 145-152
141. 141 Demolombe S, Escande D (1996) Trends Pharmacol Sci 17, 273-275